Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1997 Jan;62(1):2–8. doi: 10.1136/jnnp.62.1.2

Surgery for Parkinson's disease.

J A Obeso, J Guridi, J A Obeso, M DeLong
PMCID: PMC486685  PMID: 9010390

Full text

PDF
6

Images in this article

3Image
on p.3
8Image
on p.8

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander G. E., Crutcher M. D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990 Jul;13(7):266–271. doi: 10.1016/0166-2236(90)90107-l. [DOI] [PubMed] [Google Scholar]
  2. Aziz T. Z., Peggs D., Sambrook M. A., Crossman A. R. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord. 1991;6(4):288–292. doi: 10.1002/mds.870060404. [DOI] [PubMed] [Google Scholar]
  3. BRAVO G. J., COOPER I. S. A clinical and radiological correlation of the lesions produced by chemopallidectomy and thalamectomy. J Neurol Neurosurg Psychiatry. 1959 Feb;22(1):1–10. doi: 10.1136/jnnp.22.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Benabid A. L., Pollak P., Gao D., Hoffmann D., Limousin P., Gay E., Payen I., Benazzouz A. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg. 1996 Feb;84(2):203–214. doi: 10.3171/jns.1996.84.2.0203. [DOI] [PubMed] [Google Scholar]
  5. Benabid A. L., Pollak P., Gervason C., Hoffmann D., Gao D. M., Hommel M., Perret J. E., de Rougemont J. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet. 1991 Feb 16;337(8738):403–406. doi: 10.1016/0140-6736(91)91175-t. [DOI] [PubMed] [Google Scholar]
  6. Bergman H., Wichmann T., DeLong M. R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science. 1990 Sep 21;249(4975):1436–1438. doi: 10.1126/science.2402638. [DOI] [PubMed] [Google Scholar]
  7. Bevan M. D., Bolam J. P. Cholinergic, GABAergic, and glutamate-enriched inputs from the mesopontine tegmentum to the subthalamic nucleus in the rat. J Neurosci. 1995 Nov;15(11):7105–7120. doi: 10.1523/JNEUROSCI.15-11-07105.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Blond S., Caparros-Lefebvre D., Parker F., Assaker R., Petit H., Guieu J. D., Christiaens J. L. Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurg. 1992 Jul;77(1):62–68. doi: 10.3171/jns.1992.77.1.0062. [DOI] [PubMed] [Google Scholar]
  9. COOPER I. S., BRAVO G. Chemopallidectomy and chemothalamectomy. J Neurosurg. 1958 May;15(3):244–250. doi: 10.3171/jns.1958.15.3.0244. [DOI] [PubMed] [Google Scholar]
  10. Ceballos-Baumann A. O., Obeso J. A., Vitek J. L., Delong M. R., Bakay R., Linazasoro G., Brooks D. J. Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease. Lancet. 1994 Sep 17;344(8925):814–814. doi: 10.1016/s0140-6736(94)92369-8. [DOI] [PubMed] [Google Scholar]
  11. Chase T. N., Baronti F., Fabbrini G., Heuser I. J., Juncos J. L., Mouradian M. M. Rationale for continuous dopaminomimetic therapy of Parkinson's disease. Neurology. 1989 Nov;39(11 Suppl 2):7–19. [PubMed] [Google Scholar]
  12. Crossman A. R., Mitchell I. J., Sambrook M. A. Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey. Neuropharmacology. 1985 Jun;24(6):587–591. doi: 10.1016/0028-3908(85)90070-x. [DOI] [PubMed] [Google Scholar]
  13. DeLong M. R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 1990 Jul;13(7):281–285. doi: 10.1016/0166-2236(90)90110-v. [DOI] [PubMed] [Google Scholar]
  14. Dogali M., Fazzini E., Kolodny E., Eidelberg D., Sterio D., Devinsky O., Berić A. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology. 1995 Apr;45(4):753–761. doi: 10.1212/wnl.45.4.753. [DOI] [PubMed] [Google Scholar]
  15. Friedman J. H., Epstein M., Sanes J. N., Lieberman P., Cullen K., Lindquist C., Daamen M. Gamma knife pallidotomy in advanced Parkinson's disease. Ann Neurol. 1996 Apr;39(4):535–538. doi: 10.1002/ana.410390416. [DOI] [PubMed] [Google Scholar]
  16. GUIOT G., BRION S. Traitement des mouvements anormaux par la coagulation pallidale; technique et résultats. Rev Neurol (Paris) 1953;89(6):578–580. [PubMed] [Google Scholar]
  17. Grafton S. T., Waters C., Sutton J., Lew M. F., Couldwell W. Pallidotomy increases activity of motor association cortex in Parkinson's disease: a positron emission tomographic study. Ann Neurol. 1995 Jun;37(6):776–783. doi: 10.1002/ana.410370611. [DOI] [PubMed] [Google Scholar]
  18. Guridi J., Herrero M. T., Luquin M. R., Guillén J., Ruberg M., Laguna J., Vila M., Javoy-Agid F., Agid Y., Hirsch E. Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. Brain. 1996 Oct;119(Pt 5):1717–1727. doi: 10.1093/brain/119.5.1717. [DOI] [PubMed] [Google Scholar]
  19. Guridi J., Luquin M. R., Herrero M. T., Obeso J. A. The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease. Mov Disord. 1993 Oct;8(4):421–429. doi: 10.1002/mds.870080402. [DOI] [PubMed] [Google Scholar]
  20. Hamada I., DeLong M. R. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. J Neurophysiol. 1992 Nov;68(5):1859–1866. doi: 10.1152/jn.1992.68.5.1859. [DOI] [PubMed] [Google Scholar]
  21. Herrero M. T., Levy R., Ruberg M., Luquin M. R., Villares J., Guillen J., Faucheux B., Javoy-Agid F., Guridi J., Agid Y. Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum. Neurology. 1996 Jul;47(1):219–224. doi: 10.1212/wnl.47.1.219. [DOI] [PubMed] [Google Scholar]
  22. Hikosaka O., Wurtz R. H. Visual and oculomotor functions of monkey substantia nigra pars reticulata. IV. Relation of substantia nigra to superior colliculus. J Neurophysiol. 1983 May;49(5):1285–1301. doi: 10.1152/jn.1983.49.5.1285. [DOI] [PubMed] [Google Scholar]
  23. Iacono R. P., Shima F., Lonser R. R., Kuniyoshi S., Maeda G., Yamada S. The results, indications, and physiology of posteroventral pallidotomy for patients with Parkinson's disease. Neurosurgery. 1995 Jun;36(6):1118–1127. doi: 10.1227/00006123-199506000-00008. [DOI] [PubMed] [Google Scholar]
  24. Inzelberg R., Korczyn A. D. Persistent hemiballism in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):1013–1014. doi: 10.1136/jnnp.57.8.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kelly P. J., Gillingham F. J. The long-term results of stereotaxic surgery and L-dopa therapy in patients with Parkinson's disease. A 10-year follow-up study. J Neurosurg. 1980 Sep;53(3):332–337. doi: 10.3171/jns.1980.53.3.0332. [DOI] [PubMed] [Google Scholar]
  26. Kordower J. H., Freeman T. B., Snow B. J., Vingerhoets F. J., Mufson E. J., Sanberg P. R., Hauser R. A., Smith D. A., Nauert G. M., Perl D. P. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med. 1995 Apr 27;332(17):1118–1124. doi: 10.1056/NEJM199504273321702. [DOI] [PubMed] [Google Scholar]
  27. Laitinen L. V., Bergenheim A. T., Hariz M. I. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg. 1992 Jan;76(1):53–61. doi: 10.3171/jns.1992.76.1.0053. [DOI] [PubMed] [Google Scholar]
  28. Laitinen L. V. Brain targets in surgery for Parkinson's disease. Results of a survey of neurosurgeons. J Neurosurg. 1985 Mar;62(3):349–351. doi: 10.3171/jns.1985.62.3.0349. [DOI] [PubMed] [Google Scholar]
  29. Lenz F. A., Kwan H. C., Martin R. L., Tasker R. R., Dostrovsky J. O., Lenz Y. E. Single unit analysis of the human ventral thalamic nuclear group. Tremor-related activity in functionally identified cells. Brain. 1994 Jun;117(Pt 3):531–543. doi: 10.1093/brain/117.3.531. [DOI] [PubMed] [Google Scholar]
  30. Limousin P., Pollak P., Benazzouz A., Hoffmann D., Le Bas J. F., Broussolle E., Perret J. E., Benabid A. L. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. 1995 Jan 14;345(8942):91–95. doi: 10.1016/s0140-6736(95)90062-4. [DOI] [PubMed] [Google Scholar]
  31. Limousin P., Pollak P., Hoffmann D., Benazzouz A., Perret J. E., Benabid A. L. Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Mov Disord. 1996 May;11(3):231–235. doi: 10.1002/mds.870110303. [DOI] [PubMed] [Google Scholar]
  32. Lindvall O., Widner H., Rehncrona S., Brundin P., Odin P., Gustavii B., Frackowiak R., Leenders K. L., Sawle G., Rothwell J. C. Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol. 1992 Feb;31(2):155–165. doi: 10.1002/ana.410310206. [DOI] [PubMed] [Google Scholar]
  33. Lozano A. M., Lang A. E., Galvez-Jimenez N., Miyasaki J., Duff J., Hutchinson W. D., Dostrovsky J. O. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet. 1995 Nov 25;346(8987):1383–1387. doi: 10.1016/s0140-6736(95)92404-3. [DOI] [PubMed] [Google Scholar]
  34. Mitchell I. J., Clarke C. E., Boyce S., Robertson R. G., Peggs D., Sambrook M. A., Crossman A. R. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience. 1989;32(1):213–226. doi: 10.1016/0306-4522(89)90120-6. [DOI] [PubMed] [Google Scholar]
  35. NARABAYASHI H., OKUMA T., SHIKIBA S. Procaine oil blocking of the globus pallidus. AMA Arch Neurol Psychiatry. 1956 Jan;75(1):36–48. doi: 10.1001/archneurpsyc.1956.02330190052003. [DOI] [PubMed] [Google Scholar]
  36. Narabayashi H., Yokochi F., Nakajima Y. Levodopa-induced dyskinesia and thalamotomy. J Neurol Neurosurg Psychiatry. 1984 Aug;47(8):831–839. doi: 10.1136/jnnp.47.8.831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Obeso J. A., Grandas F., Vaamonde J., Luquin M. R., Artieda J., Lera G., Rodriguez M. E., Martinez-Lage J. M. Motor complications associated with chronic levodopa therapy in Parkinson's disease. Neurology. 1989 Nov;39(11 Suppl 2):11–19. [PubMed] [Google Scholar]
  38. Obeso J. A., Linazasoro G., Rothwell J. C., Jahanshahi M., Brown R. Assessing the effects of pallidotomy in Parkinson's disease. Lancet. 1996 May 25;347(9013):1490–1490. doi: 10.1016/s0140-6736(96)91728-6. [DOI] [PubMed] [Google Scholar]
  39. Ohye C., Shibazaki T., Hirai T., Wada H., Hirato M., Kawashima Y. Further physiological observations on the ventralis intermedius neurons in the human thalamus. J Neurophysiol. 1989 Mar;61(3):488–500. doi: 10.1152/jn.1989.61.3.488. [DOI] [PubMed] [Google Scholar]
  40. Quinn N. Multiple system atrophy--the nature of the beast. J Neurol Neurosurg Psychiatry. 1989 Jun;Suppl:78–89. doi: 10.1136/jnnp.52.suppl.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. SVENNILSON E., TORVIK A., LOWE R., LEKSELL L. Treatment of parkinsonism by stereotatic thermolesions in the pallidal region. A clinical evaluation of 81 cases. Acta Psychiatr Scand. 1960;35:358–377. doi: 10.1111/j.1600-0447.1960.tb07606.x. [DOI] [PubMed] [Google Scholar]
  42. Sellal F., Hirsch E., Lisovoski F., Mutschler V., Collard M., Marescaux C. Contralateral disappearance of parkinsonian signs after subthalamic hematoma. Neurology. 1992 Jan;42(1):255–256. doi: 10.1212/wnl.42.1.255. [DOI] [PubMed] [Google Scholar]
  43. Sutton J. P., Couldwell W., Lew M. F., Mallory L., Grafton S., DeGiorgio C., Welsh M., Apuzzo M. L., Ahmadi J., Waters C. H. Ventroposterior medial pallidotomy in patients with advanced Parkinson's disease. Neurosurgery. 1995 Jun;36(6):1112–1117. doi: 10.1227/00006123-199506000-00007. [DOI] [PubMed] [Google Scholar]
  44. Tasker R. R. Thalamotomy. Neurosurg Clin N Am. 1990 Oct;1(4):841–864. [PubMed] [Google Scholar]
  45. Tokuno H., Takada M. Common structural organization of two output nuclei of primate basal ganglia. Trends Neurosci. 1993 Aug;16(8):308–310. doi: 10.1016/0166-2236(93)90105-u. [DOI] [PubMed] [Google Scholar]
  46. Vidaković A., Dragasević N., Kostić V. S. Hemiballism: report of 25 cases. J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):945–949. doi: 10.1136/jnnp.57.8.945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Vila M., Herrero M. T., Levy R., Faucheux B., Ruberg M., Guillen J., Luquin M. R., Guridi J., Javoy-Agid F., Agid Y. Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes. Neurology. 1996 Mar;46(3):802–809. doi: 10.1212/wnl.46.3.802. [DOI] [PubMed] [Google Scholar]
  48. Wichmann T., Bergman H., DeLong M. R. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophysiol. 1994 Aug;72(2):521–530. doi: 10.1152/jn.1994.72.2.521. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES